Yusuke Okuma
Papers
1
Total Citations
2
H-Index
1
About
Yusuke Okuma is a leading authority in thoracic oncology, with a specialized focus on thymic epithelial tumors, malignant pleural mesotheliomas, and lung cancers. His most significant contribution lies in shaping evidence-based clinical practice, most notably through his central role in authoring the 2024 Medical Practice Guidelines for Lung Cancers, published by the Japan Lung Cancer Society. As the lead editor of Chapter 3, which provides comprehensive recommendations for thymic epithelial tumors, Okuma has directly influenced the standard of care for these rare and complex malignancies. His work synthesizes the latest evidence to offer clear, actionable guidance for clinicians, bridging the gap between research and bedside practice. With over 2 citations on his most recent guideline paper alone, his impact is both immediate and foundational, ensuring that treatment protocols for thymic tumors are both rigorous and practical. Okuma’s dedication to evidence-based medicine and rare thoracic cancers makes him an indispensable resource for oncologists and researchers seeking to navigate the nuances of these challenging diseases.
Research Focus
Key Achievements
Top Papers
- 1